Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1996 1
1997 2
1998 2
1999 3
2000 3
2001 2
2002 8
2003 19
2004 10
2005 15
2006 11
2007 13
2008 15
2009 19
2010 14
2011 12
2012 14
2013 17
2014 17
2015 14
2016 5
2017 7
2018 9
2019 3
2020 13
2021 13
2022 5
2023 2
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Melanotan II: a possible cause of renal infarction: review of the literature and case report.
Peters B, Hadimeri H, Wahlberg R, Afghahi H. Peters B, et al. CEN Case Rep. 2020 May;9(2):159-161. doi: 10.1007/s13730-020-00447-z. Epub 2020 Jan 18. CEN Case Rep. 2020. PMID: 31953620 Free PMC article. Review.
Melanotan II inducing rhabdomyolysis and renal failure have been described previously. We present a review of Melanotan II and the possible effects of this drug on the kidneys by including a case of a renal infarction most likely attributed to Melan …
Melanotan II inducing rhabdomyolysis and renal failure have been described previously. We present a review of Melanotan …
Melanotan-II reverses memory impairment induced by a short-term HF diet.
Wekwejt P, Wojda U, Kiryk A. Wekwejt P, et al. Biomed Pharmacother. 2023 Sep;165:115129. doi: 10.1016/j.biopha.2023.115129. Epub 2023 Jul 19. Biomed Pharmacother. 2023. PMID: 37478579 Free article.
Here, we investigated the possible relationship among diet, Melanotan-II (MT-II) targeting melanotropin receptors, and the behavior of zebrafish (Danio rerio). ...
Here, we investigated the possible relationship among diet, Melanotan-II (MT-II) targeting melanotropin receptors, and the beh …
Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Gilhooley E, Daly S, McKenna D. Gilhooley E, et al. Dermatology. 2021;237(6):995-999. doi: 10.1159/000514492. Epub 2021 Aug 31. Dermatology. 2021. PMID: 34464955
BACKGROUND: Melanotan II (MT II) is a synthetic analogue of alpha-melanocyte-stimulating hormone that, via interaction with the melanocortin 1 receptor, induces skin hyperpigmentation. ...
BACKGROUND: Melanotan II (MT II) is a synthetic analogue of alpha-melanocyte-stimulating hormone that, via interaction with th …
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.
Tomassi S, Dimmito MP, Cai M, D'Aniello A, Del Bene A, Messere A, Liu Z, Zhu T, Hruby VJ, Stefanucci A, Cosconati S, Mollica A, Di Maro S. Tomassi S, et al. J Med Chem. 2022 Mar 10;65(5):4007-4017. doi: 10.1021/acs.jmedchem.1c01848. Epub 2022 Feb 21. J Med Chem. 2022. PMID: 35188390
Here, by deploying the Chemical Linkage of Peptide onto Scaffolds strategy, we replaced the lactam cyclization of melanotan II (MT-II), a potent and unselective agonist of human MCRs (hMCRs), with different xylene-derived thioethers. ...
Here, by deploying the Chemical Linkage of Peptide onto Scaffolds strategy, we replaced the lactam cyclization of melanotan II …
Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism.
Minakova E, Lang J, Medel-Matus JS, Gould GG, Reynolds A, Shin D, Mazarati A, Sankar R. Minakova E, et al. PLoS One. 2019 Jan 10;14(1):e0210389. doi: 10.1371/journal.pone.0210389. eCollection 2019. PLoS One. 2019. PMID: 30629642 Free PMC article.
One pharmacological approach to stimulating oxytocinergic activity is the melanocortin receptor 4 agonist Melanotan-II (MT-II). Notably the effects of oxytocin on environmental rodent autism models has not been investigated to date. ...
One pharmacological approach to stimulating oxytocinergic activity is the melanocortin receptor 4 agonist Melanotan-II (MT-II) …
Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food.
Eliason NL, Martin L, Low MJ, Sharpe AL. Eliason NL, et al. Neuropeptides. 2022 Dec;96:102289. doi: 10.1016/j.npep.2022.102289. Epub 2022 Sep 16. Neuropeptides. 2022. PMID: 36155088 Free PMC article.
METHODS: Male, C57BL/6J mice were microinjected bilaterally into the NAcc (100 nl/side) with the melanocortin receptor 3/4 agonist melanotan-II (MT-II; 0.1, 0.3, and 1 nmol), and ingestive behaviors were examined in both home cage and operant food self-administratio …
METHODS: Male, C57BL/6J mice were microinjected bilaterally into the NAcc (100 nl/side) with the melanocortin receptor 3/4 agonist melano …
Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase-activating polypeptide deficient mice.
McMillan TR, Forster MAM, Short LI, Rudecki AP, Cline DL, Gray SL. McMillan TR, et al. Exp Physiol. 2021 Feb;106(2):427-437. doi: 10.1113/EP088838. Epub 2020 Dec 17. Exp Physiol. 2021. PMID: 33332767 Free article.
Can chronic treatment of pituitary adenylate cyclase-activating polypeptide (PACAP) deficient mice with the melanocortin agonist melanotan II during cold acclimation rescue the impaired thermogenic capacity previously observed in PACAP deficient mice? ...To assess t …
Can chronic treatment of pituitary adenylate cyclase-activating polypeptide (PACAP) deficient mice with the melanocortin agonist melanota …
Melanoma associated with the use of melanotan-II.
Hjuler KF, Lorentzen HF. Hjuler KF, et al. Dermatology. 2014;228(1):34-6. doi: 10.1159/000356389. Epub 2013 Dec 18. Dermatology. 2014. PMID: 24355990
BACKGROUND: Unlicensed use of melanotan-II (MT-II) to promote skin pigmentation has become prevalent amongst young people attending fitness centres. ...
BACKGROUND: Unlicensed use of melanotan-II (MT-II) to promote skin pigmentation has become prevalent amongst young people atte …
241 results